Nepal regulator asks Patanjali to recall six ‘substandard’ products

June 23, 2017, 3:17 pm
Nepal regulator  asks Patanjali to recall six ‘substandard’ products
BUSINESS NEWS
BUSINESS NEWS
Nepal regulator  asks Patanjali to recall six ‘substandard’ products

Nepal regulator asks Patanjali to recall six ‘substandard’ products

After they were found to be of “substandard quality” following microbial tests, Nepal’s drugs watchdog has asked Ramdev’s Patanjali Ayurveda to recall its six Ayurvedic medicines from the market.

The Department of Drug Administration, in a public notice, said six Ayurvedic medical products made by Divya Pharmacy in Uttarakhand, were found to be substandard during inspections at various outlets and tests on specimens.

The medicines which failed the microbial tests are Patanjali's Amla Churna, Divya Gashar Churna, Bahuchi Churna, Triphala Churna, Aswangandha and Adviya Churna, the notice said.

The batch of medicine which were inspected by the department are found to have contained pathogenic bacteria
Department of Drug Administration

The Nepalese drug authorities have urged the stakeholders not to sell or prescribe the use of these six medicines with immediate effect.

A source at Patanjali Ayurveda Kendra in Kathmandu, the sole distributor of the products in Nepal, said the medicines have not been banned but restriction was imposed on the sale and use of certain batch of the medicines that failed lab test.

“We will immediately recall the medicines if found substandard,” he said

The authorities have asked the Patanjali Ayurveda unit in Nepal to inform them about steps being taken to recall the products in line with local medicine laws. In addition, Bengaluru-based Micro Lab Limited, which makes the Indian manufactured drug, Bactoclav also received the same order.